DE69937307D1 - Imidazol verbindungen und ihre medizinische verwendung - Google Patents

Imidazol verbindungen und ihre medizinische verwendung

Info

Publication number
DE69937307D1
DE69937307D1 DE69937307T DE69937307T DE69937307D1 DE 69937307 D1 DE69937307 D1 DE 69937307D1 DE 69937307 T DE69937307 T DE 69937307T DE 69937307 T DE69937307 T DE 69937307T DE 69937307 D1 DE69937307 D1 DE 69937307D1
Authority
DE
Germany
Prior art keywords
medical use
imidazol compounds
imidazol
compounds
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69937307T
Other languages
English (en)
Other versions
DE69937307T2 (de
Inventor
Hiroshi Kayakiri
Yoshito Abe
Hitoshi Hamashima
Hitoshi Sawada
Naoki Ishibashi
Hiroyuki Setoi
Teruo Oku
Noritsugu Yamasaki
Takafumi Imoto
Takahiro Hiramura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Application granted granted Critical
Publication of DE69937307D1 publication Critical patent/DE69937307D1/de
Publication of DE69937307T2 publication Critical patent/DE69937307T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • C07D233/94Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69937307T 1998-12-24 1999-12-20 Imidazol verbindungen und ihre medizinische verwendung Expired - Fee Related DE69937307T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP36736298 1998-12-24
JP36736298 1998-12-24
JP22883899 1999-08-12
JP22883899 1999-08-12
PCT/JP1999/007160 WO2000039097A1 (fr) 1998-12-24 1999-12-20 Composes d'imidazole et utilisation medicinale de ces composes

Publications (2)

Publication Number Publication Date
DE69937307D1 true DE69937307D1 (de) 2007-11-22
DE69937307T2 DE69937307T2 (de) 2008-02-07

Family

ID=26528483

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69937307T Expired - Fee Related DE69937307T2 (de) 1998-12-24 1999-12-20 Imidazol verbindungen und ihre medizinische verwendung

Country Status (19)

Country Link
US (1) US7060721B1 (de)
EP (1) EP1142879B1 (de)
KR (1) KR20010094731A (de)
CN (1) CN1170822C (de)
AR (1) AR022019A1 (de)
AT (1) ATE375332T1 (de)
AU (1) AU758325C (de)
BR (1) BR9917112A (de)
CA (1) CA2356838A1 (de)
CZ (1) CZ20012338A3 (de)
DE (1) DE69937307T2 (de)
ES (1) ES2292262T3 (de)
HK (1) HK1043791A1 (de)
HU (1) HUP0104657A3 (de)
IL (1) IL143802A0 (de)
RU (1) RU2238937C2 (de)
TR (1) TR200101865T2 (de)
TW (1) TWI239330B (de)
WO (1) WO2000039097A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0009037D0 (en) * 2000-04-13 2000-05-31 Novartis Ag Organic compounds
US20030181461A1 (en) * 2002-01-25 2003-09-25 Lautt Wilfred Wayne Use of phosphodiesterase antagonists to treat insulin resistance
AU2012200214B2 (en) * 2004-05-14 2013-10-24 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
ES2249992B1 (es) * 2004-09-13 2007-03-01 Ferrer Internacional, S.A. Un procedimiento para fabricar compuestos enantiomericos del imidazol.
JP4094660B1 (ja) * 2005-08-10 2008-06-04 武田薬品工業株式会社 糖尿病治療剤
JP2009534366A (ja) * 2006-04-21 2009-09-24 アストラゼネカ アクチボラグ Edg−1拮抗剤として使用するためのイミダゾール誘導体
TW200838501A (en) 2007-02-02 2008-10-01 Theravance Inc Dual-acting antihypertensive agents
TW200838515A (en) * 2007-02-09 2008-10-01 Takeda Pharmaceutical Fused ring compound
TWI448284B (zh) 2007-04-24 2014-08-11 Theravance Inc 雙效抗高血壓劑
TWI406850B (zh) 2007-06-05 2013-09-01 Theravance Inc 雙效苯并咪唑抗高血壓劑
KR100868898B1 (ko) * 2007-07-30 2008-11-14 한국기계연구원 적층형 pzt를 이용한 압전펌프
JP2010538071A (ja) 2007-09-07 2010-12-09 セラヴァンス, インコーポレーテッド 二重作用性降圧剤
ES2385773T3 (es) 2007-12-11 2012-07-31 Theravance, Inc. Derivados de benzoimidazol, de doble acción, y su utilización como agentes antihipertensivos
EP2297113A1 (de) 2008-04-29 2011-03-23 Theravance, Inc. Blutdrucksenkende mittel mit dualer wirkung
US8124636B2 (en) * 2008-04-30 2012-02-28 Hoffmann-La Roche Inc. Imidazolidinone derivatives as 11B-HSD1 inhibitors
WO2010011821A2 (en) 2008-07-24 2010-01-28 Theravance, Inc. Dual-acting antihypertensive agents
BRPI1010571A2 (pt) * 2009-05-15 2019-09-24 Sanofi Sa processo para a preparação de um composto útil como um inibidor de tafla.
JP5833000B2 (ja) 2009-07-07 2015-12-16 セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー 二重に作用するピラゾール抗高血圧症薬
JP2012533626A (ja) 2009-07-22 2012-12-27 セラヴァンス, インコーポレーテッド 二重作用オキサゾール降圧剤
EP2526095A1 (de) 2010-01-19 2012-11-28 Theravance, Inc. Doppelt wirkende blutdrucksenkende thiophen-, pyrrol-, thiazol- und furan-mittel
AU2019337018B2 (en) * 2018-09-04 2024-03-07 Chugai Seiyaku Kabushiki Kaisha Method of producing tetracyclic compound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215994A (en) 1990-09-25 1993-06-01 Fujisawa Pharmaceutical Co., Ltd. Angiotenin II antagonizing heterocyclic derivatives
TW235963B (de) 1992-01-16 1994-12-11 Shionogi & Co
IL124969A (en) 1995-12-28 2002-09-12 Fujisawa Pharmaceutical Co History of benzimidazole, processes for their preparation and pharmaceutical preparations containing them
EP1000932B9 (de) 1997-06-27 2005-12-28 Fujisawa Pharmaceutical Co., Ltd. Derivate mit einem aromatischen ring
US6348474B1 (en) 1997-06-27 2002-02-19 Fujisawa Pharmaceutical Co., Ltd. Sulfonamide compounds and medicinal use thereof

Also Published As

Publication number Publication date
EP1142879B1 (de) 2007-10-10
CN1335837A (zh) 2002-02-13
HK1043791A1 (en) 2002-09-27
CA2356838A1 (en) 2000-07-06
TR200101865T2 (tr) 2001-12-21
HUP0104657A2 (hu) 2002-05-29
KR20010094731A (ko) 2001-11-01
DE69937307T2 (de) 2008-02-07
WO2000039097A1 (fr) 2000-07-06
ES2292262T3 (es) 2008-03-01
AU1690500A (en) 2000-07-31
BR9917112A (pt) 2002-01-29
US7060721B1 (en) 2006-06-13
EP1142879A1 (de) 2001-10-10
AU758325B2 (en) 2003-03-20
ATE375332T1 (de) 2007-10-15
RU2238937C2 (ru) 2004-10-27
AR022019A1 (es) 2002-09-04
CZ20012338A3 (cs) 2001-12-12
TWI239330B (en) 2005-09-11
HUP0104657A3 (en) 2002-07-29
EP1142879A4 (de) 2002-02-06
AU758325C (en) 2004-10-07
IL143802A0 (en) 2002-04-21
CN1170822C (zh) 2004-10-13

Similar Documents

Publication Publication Date Title
DE69937307D1 (de) Imidazol verbindungen und ihre medizinische verwendung
DE60123041D1 (de) Entzündungshemmende verbindungen und ihre verwendung
ATE370931T1 (de) Heterozyklische verbindungen und ihre verwendungen
DE69927946D1 (de) Verkalkungsbeständige medizinische artikel
DE60036803D1 (de) Arylmethyl-carbonylamino-thiazolderivate und ihre verwendung als antitumormittel
ATE277910T1 (de) Urazil verbindungen und deren verwendung
DE60027479D1 (de) Harzstruktur und ihre verwendung
DE60016326D1 (de) Wasser-absorbierende Zusammensetzung und ihre Verwendung
ATE261449T1 (de) Thienopyrimidin verbindungen, ihre herstellung und verwendung
DE60127997D1 (de) 1,5-benzothiazepine und ihre verwendung als antihyperlipidämika
DE69424853T2 (de) Morphinan-derivate und ihre medizinische verwendung
DE69404382T2 (de) Urea-Derivate und ihre Verwendung als ACAT-hemmenden Verbindungen
DE59710422D1 (de) Acylmercapto-triazolyl-derivate und ihre verwendung als mikrobizide
DE60003874D1 (de) Resistmaterialien und Verbindungen
DE60019312D1 (de) Medizinische laserfeste fassvorrichtung
DE59710580D1 (de) Thiocyano-triazolyl-derivate und ihre verwendung als mikrobizide
DE60223841D1 (de) Medizinische verwendung von gsk3-hemmenden oxindolderivaten
DE60027927D1 (de) Harzstruktur und ihre verwendung
DE69939068D1 (de) Entfernbare implantierbare medizinische leitung
DE69921469D1 (de) Medizinische elektrodenleitung
DE59908549D1 (de) Strahlungsempfindliches Gemisch und dessen Verwendung
DE69902387D1 (de) Oxadiazolinderivate und ihre verwendung als insektizide
DE69917777D1 (de) Benzazol-verbindungen und ihre verwendung
DE59906907D1 (de) Phosphororganische verbindungen und ihre verwendung
DE59902692D1 (de) Phosphororganische verbindungen und ihre verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee